Immediate Injection of Botulinum Toxin Type A After Keloid Scar Revision to Prevent Keloid Recurrence: a Prospective, Split-scar, Double-blind, Randomized Controlled Study
Latest Information Update: 23 Nov 2023
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Keloids
- Focus Therapeutic Use
- 14 Nov 2023 Planned End Date changed from 1 Dec 2023 to 20 Mar 2024.
- 14 Nov 2023 Planned primary completion date changed from 1 Dec 2023 to 20 Mar 2024.
- 14 Nov 2023 Status changed from recruiting to active, no longer recruiting.